TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q). Br J Haematol. 2024 Apr; 204(4):1243-1248.